Kelly, Peter J.

Variants conferring risk of atrial fibrillation on chromosome 4q25

Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., Jonasdottir, A., Baker, A., Thorleifsson, G., Kristjansson, K., et al. (2007) · Nature

Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Cited by 955

Neurological manifestations and implications of COVID-19 pandemic

Tsivgoulis, G., Palaiodimou, L., Katsanos, A. H., Caso, V., Köhrmann, M., Molina, C., Cordonnier, C., Fischer, U., Kelly, P., Sharma, V. K., et al. (2020) · Therapeutic Advances in Neurological Disorders

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 145

Reduction in early stroke risk in carotid stenosis with transient ischemic attack associated with statin treatment

Merwick, Á., Albers, G. W., Arsava, E. M., Ay, H., Calvet, D., Coutts, S. B., Cucchiara, B. L., Demchuk, A. M., Giles, M. F., Mas, J.-L., et al. (2013) · Stroke

Cerebrovascular and Carotid Artery DiseasesAcute Ischemic Stroke Management

Cited by 89

Symptom development and prognosis in primary biliary cirrhosis: a study in two centers

Mitchison, H. C., Lucey, M. R., Kelly, P. J., Neuberger, J. M., Williams, R., & James, O. F. W. (1990) · Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 74

Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis

Stefanou, M.-I., Palaiodimou, L., Theodorou, A., Safouris, A., Fischer, U., Kelly, P. J., Dawson, J., Katan, M., Katsanos, A. H., Lambadiari, V., et al. (2024) · Therapeutic Advances in Neurological Disorders

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 36